BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7561956)

  • 1. Is dystrophin always altered in Becker muscular dystrophy patients?
    Vainzof M; Passos-Bueno MR; Pavanello RC; Zatz M
    J Neurol Sci; 1995 Jul; 131(1):99-104. PubMed ID: 7561956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limb-girdle syndrome: a genetic study of 22 large Brazilian families. Comparison with X-linked Duchenne and Becker dystrophies.
    Passos-Bueno MR; Vainzof M; Pavanello Rde C; Pavanello-Filho I; Lima MA; Zatz M
    J Neurol Sci; 1991 May; 103(1):65-75. PubMed ID: 1865235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
    J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
    Jay V; Becker LE; Ackerley C; Ray P
    Pediatr Pathol; 1993; 13(5):635-57. PubMed ID: 8247961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal dystrophin expression in patients with limb girdle syndromes.
    Beyenburg S; Zierz S; Arahata K; Mundegar RR; Friedl W; Jerusalem F
    J Neurol; 1994 Feb; 241(4):210-7. PubMed ID: 8195819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
    Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
    J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diagnosis of Becker muscular dystrophy by dystrophin testing.
    Hoffman EP; Kunkel LM; Angelini C; Clarke A; Johnson M; Harris JB
    Neurology; 1989 Aug; 39(8):1011-7. PubMed ID: 2668783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes.
    Norman A; Thomas N; Coakley J; Harper P
    Lancet; 1989 Mar; 1(8636):466-8. PubMed ID: 2563842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcolemmal distribution of abnormal dystrophin in Xp21 carriers.
    Vainzof M; Nicholson LV; Bulman DE; Tsanaclis AM; Passos-Bueno MR; Pavanello RC; Zatz M
    Neuromuscul Disord; 1993 Mar; 3(2):135-40. PubMed ID: 7689380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
    J Med Genet; 1993 Sep; 30(9):737-44. PubMed ID: 8411068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
    Simard LR; Gingras F; Delvoye N; Vanasse M; Melançon SB; Labuda D
    Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
    Uchino M; Miike T; Iwashita H; Uyama E; Yoshioka K; Sugino S; Ando M
    J Neurol Sci; 1994 Jul; 124(2):225-9. PubMed ID: 7964876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
    Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
    Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
    Arikawa E; Hoffman EP; Kaido M; Nonaka I; Sugita H; Arahata K
    Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
    Vainzof M; Takata RI; Passos-Bueno MR; Pavanello RC; Zatz M
    Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin analysis in the diagnosis of muscular dystrophy.
    Norman AM; Hughes HE; Gardner-Medwin D; Nicholson LV
    Arch Dis Child; 1989 Oct; 64(10):1501-3. PubMed ID: 2684033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage analysis in families with autosomal recessive limb-girdle muscular dystrophy (LGMD) and 6q probes flanking the dystrophin-related sequence.
    Passos-Bueno MR; Terwilliger J; Ott J; Vainzof M; Love DR; Davies KE; Zatz M
    Am J Med Genet; 1991 Jan; 38(1):140-6. PubMed ID: 2012126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.